1 Min Read
Dec 7 (Reuters) - Abbott Laboratories said on Wednesday it had filed a complaint in the Delaware Court of Chancery to terminate its proposed acquisition of Alere Inc , citing a "substantial loss" in the value of the diagnostics company.
Abbott agreed earlier this year to buy Alere for $5.8 billion, giving it access to Alere's diagnostic tests performed at home and in doctors' offices and hospitals.
Alere has suffered a series of damaging business developments in the 10 months following the signing of the agreement, Abbott said. (Reporting by Natalie Grover in Bengaluru; Editing by Ted Kerr)